Investing
Proceeds from Sale of Seagen Inc. Common Stock
Berkshire Hathaway Proceeds from Sale of Seagen Inc. Common Stock increased by 262.8% to $24.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 415.0%, from $4.68B to $24.09B. Over 3 years (FY 2021 to FY 2025), Proceeds from Sale of Seagen Inc. Common Stock shows an upward trend with a 24.6% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2021
Last reportedQ1 2026May 4, 2026
Metric ID:
mrk_proceeds_from_sale_of_seagen_stockHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.96B | $3.96B | $3.96B | $5.30B | $16.32B | $13.28B | $12.55B | $6.95B | $7.85B | $19.97B | $77.15B | $36.10B | $10.14B | $4.68B | $6.92B | $12.45B | $6.64B | $24.09B |
| QoQ Change | — | +0.0% | +0.0% | +33.7% | +208.0% | -18.6% | -5.5% | -44.6% | +12.8% | +154.6% | +286.3% | -53.2% | -71.9% | -53.9% | +47.9% | +80.1% | -46.7% | +262.8% |
| YoY Change | — | — | — | +33.7% | +311.9% | — | — | +31.2% | -51.9% | +50.4% | +514.7% | +419.1% | +29.3% | -76.6% | -91.0% | -65.5% | -34.5% | +415.0% |
Range$3.96B – $77.15B
CAGR+52.9%
Avg YoY Growth+114.3%
Median YoY Growth+31.2%
Proceeds from Sale of Seagen Inc. Common Stock at Other Companies
Frequently Asked Questions
- What is Berkshire Hathaway's proceeds from sale of seagen inc. common stock?
- Berkshire Hathaway (BRK.B) reported proceeds from sale of seagen inc. common stock of $24.09B in Q1 2026.
- How has Berkshire Hathaway's proceeds from sale of seagen inc. common stock changed year-over-year?
- Berkshire Hathaway's proceeds from sale of seagen inc. common stock increased by 415.0% year-over-year, from $4.68B to $24.09B.
- What is the long-term trend for Berkshire Hathaway's proceeds from sale of seagen inc. common stock?
- Over 3 years (2021 to 2025), Berkshire Hathaway's proceeds from sale of seagen inc. common stock has grown at a 24.6% compound annual growth rate (CAGR), from $15.85B to $30.69B.